Despite the profitability miss, FY 23/24 guidance unchanged
09/02/24 -"CZM’s Q1 profitability fell short of expectations. Growth was once again led by Microsurgery, while Ophthalmology ended on a flat note. As expected, profitability was under pressure. Nonetheless, FY ..."
Pages
61
Language
English
Published on
09/02/24
You may also be interested by these reports :
07/02/25
Supported by ongoing operational improvements, Emeis delivered FY24 results ahead of guidance and provided above-consensus FY25 guidance. While the ...
07/02/25
GN’s Q4 results met market expectations. Healthy growth in the Hearing segment was counterbalanced by a weaker performance in Gaming & Consumer and ...
07/02/25
Healthineers reported a solid performance in Q1, surpassing consensus expectations with sales up +2.1%, adjusted EBIT up +2.5%, and net profit up ...
06/02/25
Qiagen’s Q4 24 results aligned with market expectations and slightly exceeded management’s guidance. Most segments demonstrated healthy sales growth. ...